BTG PLC | Balance Sheet

Fiscal year is April-March. All values GBP Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
43
74
143
156
210
Total Accounts Receivable
39
51
56
77
134
Inventories
27
41
47
58
61
Other Current Assets
37
43
53
51
3
Total Current Assets
146
208
298
342
408
Net Property, Plant & Equipment
31
36
36
40
41
Total Investments and Advances
4
3
2
-
-
Intangible Assets
522
782
787
905
687
Other Assets
8
13
19
19
24
Total Assets
712
1,046
1,149
1,311
1,163
Accounts Payable
14
11
16
14
20
Income Tax Payable
7
3
6
5
7
Other Current Liabilities
66
102
103
146
163
Total Current Liabilities
88
116
125
166
190
Provision for Risks & Charges
1
1
2
3
3
Deferred Taxes
90
148
140
152
46
Other Liabilities
3
18
28
6
7
Total Liabilities
181
287
301
331
250
Common Equity (Total)
530
759
848
980
915
Total Shareholders' Equity
530
759
848
980
915
Total Equity
530
759
848
980
913
Liabilities & Shareholders' Equity
712
1,046
1,149
1,311
1,163
Accumulated Minority Interest
-
-
-
-
2

About BTG

View Profile
Address
5 Fleet Place
London London & South East EC4M 7RD
United Kingdom
Employees -
Website http://btgplc.com
Updated 07/08/2019
BTG Plc is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following business segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment provides therapies for cancer, sever emphysema, and vascular conditions such as severe blood clots and varicose veins.